ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ward, C.
Right arrow Articles by Snell, G.I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ward, C.
Right arrow Articles by Snell, G.I.
Eur Respir J 2002; 19:472-478
Copyright ©ERS Journals Ltd 2002


Increased soluble CD14 in bronchoalveolar lavage fluid of stable lung transplant recipients

C. Ward1, E.H. Walters2, L. Zheng3, H. Whitford3, T.J. Williams3 and G.I. Snell3

1 William Leech Centre, Freeman Road Hospital, University of Newcastle upon Tyne, UK. 2 Dept of Medicine, University of Tasmania, Tasmania and 3 Respiratory Medicine, Alfred Hospital and Monash University Medical School, Melbourne, Australia

CORRESPONDENCE: G. Snell, Dept of Respiratory Medicine, Alfred Hospital, Prahran, Melbourne, 3181, Australia. Fax: 61392763434. E-mail: g.snell@alfred.org.au

Keywords: bronchoalveolar lavage, CD14, lung transplantation

Received: March 15, 2001
Accepted October 10, 2001

This study was supported by the Alfred Hospital Foundation, the Alfred Whole Time Medical Specialists, National Health and Medical Research Council of Australia and a grant in aid from Novartis.

Macrophages, neutrophils and infection have been implicated in the genesis of the bronchiolitis obliterans syndrome (BOS) post lung transplantation. sCD14 is a soluble form of a shed-cell surface protein. It is capable of promoting cytokine-induced inflammation and it's presence in clinically stable lung transplant recipients (LTR) might be important as an early marker of BOS.

Bronchalveolar lavage (BAL) and blood samples were taken from 26 stable LTR, at or near their best forced expiratory volume in one second who were free from infection. sCD14 levels were measured via enzyme-linked immunosorbent assay. Cell counts were performed on unfiltered BAL.

LTR neutrophil count, BAL sCD14 and serum sCD14 levels were higher than controls (median 3.8% versus 1.3%, p<0.05; 11.5 ng·mL–1 versus 6 ng·mL–1, p<0.001; 6.2 µg·mL–1 versus 2.4 µg·mL–1, p<0.05, respectively). BAL albumin and sCD14 correlated (regression coefficient: 0.77, p<0.001).

In this hypothesis-generating, cross-sectional study, the authors have described for the first time soluble CD14 levels in the bronchoalveolar lavage and serum of stable lung transplant recipients, and show that these are elevated compared to controls. This is a practicable candidate marker system, which can be tested for a predictive role in bronchiolitis obliterans syndrome following lung transplantation. The origin of this cellular protein and its temporal relationship to the development of the bronchiolitis obliterans syndrome remains to be elucidated in more definitive longitudinal studies, which should include other measurements potentially relevant to the innate immune system, such as bronchoalveolar lavage endotoxin levels.




This article has been cited by other articles:


Home page
Eur Respir JHome page
V. Regueiro, M. A. Campos, P. Morey, J. Sauleda, A.G.N. Agusti, J. Garmendia, and J. A. Bengoechea
Lipopolysaccharide-binding protein and CD14 are increased in the bronchoalveolar lavage fluid of smokers
Eur. Respir. J., February 1, 2009; 33(2): 273 - 281.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
E H Walters, R Wood-Baker, D E C Reid, and C Ward
Innate immune activation in neutrophilic asthma
Thorax, January 1, 2008; 63(1): 88 - 89.
[Full Text] [PDF]


Home page
ThoraxHome page
C Ward, I A Forrest, D M Murphy, G E Johnson, H Robertson, T E Cawston, A J Fisher, J H Dark, J L Lordan, J A Kirby, et al.
Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients
Thorax, October 1, 2005; 60(10): 865 - 871.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
C Ward, I A Forrest, I A Brownlee, G E Johnson, D M Murphy, J P Pearson, J H Dark, and P A Corris
Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allografts
Thorax, October 1, 2005; 60(10): 872 - 874.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Kanazawa, S. Nomura, M. Muramatsu, K. Yamaguchi, S. Fukuhara, S. G. Gerhardt, J. F. McDyer, R. J. Cummings, and J. B. Orens
Azithromycin and Bronchiolitis Obliterans
Am. J. Respir. Crit. Care Med., March 1, 2004; 169(5): 654 - 655.
[Full Text]


Home page
ThoraxHome page
C Ward, M Camara, I Forrest, R Rutherford, G Pritchard, M Daykin, A Hardman, A de Soyza, A J Fisher, P Williams, et al.
Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients
Thorax, May 1, 2003; 58(5): 444 - 446.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the European Respiratory Society.